Ourotech's competitors

Ourotech's competitors include Aeglea Biotherapeutics, XBiotech, Heat Biologics and Immune Design
Add company...
Ourotech
Ourotech is changing the way cancer drugs are tested for the most innovative treatments.
Aeglea Biotherapeutics
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.
XBiotech
XBiotech is a biopharmaceutical company developing first-in-class antibody therapies.
Heat Biologics
Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.
Immune Design
Immune Design develops vaccines and therapeutics for the prevention and treatment of infectious diseases.
Founding Date
Founding Date
2015
Founding Date
2013
Founding Date
2005
Founding Date
2008
Founding Date
2008
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Waterloo, CA HQ
Locations
Austin, US HQ
Locations
Austin, US HQ
Locations
Durham, US HQ
Locations
Seattle, US HQ
South San Francisco, US
Employees
Employees
433% increase
Employees
4518% increase
Employees
56
Employees
19
Employees
50
Valuation ($)
Valuation ($)
N/A
Valuation ($)
232.6 m
Valuation ($)
156.3 m
Valuation ($)
17.8 m
Valuation ($)
206.9 m
Facebook likes
Facebook likes
504
Facebook likes
N/A
Facebook likes
186
Facebook likes
110
Facebook likes
N/A
Twitter followers
Twitter followers
272
Twitter followers
N/A
Twitter followers
163
Twitter followers
N/A
Twitter followers
N/A

Financial

Net income
Net income
N/A
Net income
($27.2m) (FY, 2017)
Net income
($50.7m) (FY, 2016)
Net income
($12.4m) (FY, 2017)
Net income
($51.9m) (FY, 2017)

Operating

Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2016)
For sources of this data, please see the company profileDownload Excel

View company profiles

Aeglea Biotherapeutics
HQ
Austin, US
Employees
45↑ 18% increase

Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.

View company
XBiotech
HQ
Austin, US
Employees
56

XBiotech is a biopharmaceutical company developing first-in-class antibody therapies.

View company
Heat Biologics
HQ
Durham, US
Employees
19

Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.

View company
Immune Design
HQ
Seattle, US
Employees
50

Immune Design develops vaccines and therapeutics for the prevention and treatment of infectious diseases.

View company